search case studies
  Government    printer friendly version
 
 

Governments and Economic Communities

SHI Consulting works with regional and national agencies and governments on strategies for building the innovative life sciences sectors. Working at the nexus of government, industry and research interests, we understand the diverse needs of economic communities and the tools required for growth and competitive advantage. We provide strategies that can be rapidly implemented to ensure maximum impact.

Who does SHI Consulting work with in governments and economic communities?

We work with emerging and established life sciences communities and all levels of government, ranging from locally-based economic development agencies to national, provincial and state government ministries, departments and programs.

How can SHI Consulting help me to:

What are some of SHI's successes in working with government?

  • Strategic planning and capital sourcing for over 2 million sq. ft of infrastructure including incubators, research parks and R&D facilities for government, academia and industry
  • Development of a commercialization strategy for a national funding agency
  • Creation of strategic plans and regional investment attraction tools for the growth of five regional clusters
  • Creation of organizational strategies to ensure competitiveness in life sciences translational research
  • Creation of an investment attraction strategy to bring Greenfield investment and partnerships focused on new, emerging health technologies into a region

 

 
 
"SHI has built bridges amongst academia, government, and industry - understanding the distinct needs of each group but always finding win-win-win scenarios that lead to true impact rather than rhetoric."
 
Ken Knox 
President
Ontario Innovation Institute
 
Case Studies
Positioning the Ontario Life Science Industries in the Global Marketplace
Biotechnology Cluster Innovation Plan: Phase 1
Strategic Alliance Identification for French Biotechnology Companies Seeking Partnership Opportunities in the Canadian Biotechnology Sector